Evaluation of commercial vancomycin agar screen plates for detection of vancomycin-resistant enterococci.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print Cited Medium: Print ISSN: 0095-1137 (Print) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, American Society for Microbiology.
    • Subject Terms:
      Culture Media*; Anti-Bacterial Agents/*pharmacology ; Enterococcus/*drug effects ; Microbial Sensitivity Tests/*methods ; Vancomycin/*pharmacology; Drug Resistance, Microbial ; Evaluation Studies as Topic ; Gram-Positive Bacterial Infections/microbiology ; Humans
    • Abstract:
      Brain heart infusion-6-micrograms/ml vancomycin agar plates obtained from five commercial sources (B-D Microbiology Systems, Carr-Scarborough Microbiologicals, MicroBio Products, PML Microbiologicals, and REMEL) were evaluated with 714 enterococci for detection of vancomycin resistance. All 465 (100%) vancomycin-resistant enterococci (MIC > or = 32 micrograms/ml) were detected by each manufacturer's agar screen plate, and each manufacturer's agar screen plate detected at least 99% of the 177 vancomycin-susceptible enterococci (MIC < or = 4 micrograms/ml). Detection of the 72 vancomycin-intermediate enterococci (MIC = 6 to 16 micrograms/ml) ranged from 94% for B-D Microbiology Systems to 99% for PML Microbiologicals.
    • References:
      J Clin Microbiol. 1989 Apr;27(4):731-4. (PMID: 2656745)
      Infect Control Hosp Epidemiol. 1995 Dec;16(12):680-5. (PMID: 8683085)
      J Clin Microbiol. 1990 Mar;28(3):435-7. (PMID: 2108992)
      Am J Med. 1991 Sep 16;91(3B):72S-75S. (PMID: 1928195)
      Am J Med. 1991 Sep 16;91(3B):86S-89S. (PMID: 1928197)
      J Hosp Infect. 1992 May;21(1):1-14. (PMID: 1351492)
      J Clin Microbiol. 1992 Jul;30(7):1621-4. (PMID: 1629315)
      J Clin Microbiol. 1992 Oct;30(10):2525-8. (PMID: 1400949)
      Antimicrob Agents Chemother. 1992 Sep;36(9):2005-8. (PMID: 1416893)
      Lancet. 1993 Jul 10;342(8863):76-9. (PMID: 8100912)
      J Clin Microbiol. 1993 Jul;31(7):1695-9. (PMID: 8349745)
      J Clin Microbiol. 1993 Oct;31(10):2777-9. (PMID: 8253981)
      J Clin Microbiol. 1993 Dec;31(12):3336-9. (PMID: 8308134)
      J Clin Microbiol. 1994 Jul;32(7):1700-4. (PMID: 7929760)
      Antimicrob Agents Chemother. 1994 Aug;38(8):1788-93. (PMID: 7986009)
      Diagn Microbiol Infect Dis. 1994 Oct;20(2):113-6. (PMID: 7867304)
      J Clin Microbiol. 1995 Apr;33(4):791-3. (PMID: 7790438)
      J Clin Microbiol. 1995 Jun;33(6):1524-7. (PMID: 7650179)
      J Clin Microbiol. 1995 Jun;33(6):1643-5. (PMID: 7650204)
      J Infect Dis. 1995 Oct;172(4):993-1000. (PMID: 7561221)
      J Clin Microbiol. 1989 Sep;27(9):2140-2. (PMID: 2778080)
    • Accession Number:
      0 (Anti-Bacterial Agents)
      0 (Culture Media)
      6Q205EH1VU (Vancomycin)
    • Publication Date:
      Date Created: 19960801 Date Completed: 19961210 Latest Revision: 20210526
    • Publication Date:
      20231215
    • Accession Number:
      PMC229183
    • Accession Number:
      10.1128/jcm.34.8.2042-2044.1996
    • Accession Number:
      8818911